{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:46:31Z","timestamp":1794649591448,"version":"4.9.1"},"reference-count":34,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS113828"],"award-info":[{"award-number":["R01NS113828"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2020,12,1]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the frequency and characteristics of brainstem or cerebellar involvement in myelin-oligodendrocyte-glycoprotein-antibody-associated-disorder (MOGAD) versus aquaporin-4-IgG-seropositive-neuromyelitis optica spectrum disorder (AQP4-IgG-NMOSD) and multiple sclerosis (MS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this observational study, we retrospectively identified 185 Mayo Clinic MOGAD patients with: (1) characteristic MOGAD phenotype, (2) MOG-IgG seropositivity by live cell-based assay and (3) MRI lesion(s) of brainstem, cerebellum or both. We compared the symptomatic attacks to AQP4-IgG-NMOSD (n=30) and MS (n=30).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Brainstem or cerebellar involvement occurred in 62\/185 (34%) MOGAD patients of which 39\/62 (63%) were symptomatic. Ataxia (45%) and diplopia (26%) were common manifestations. The median age in years (range) in MOGAD of 24 (2\u201365) was younger than MS at 36 (16\u201365; p=0.046) and AQP4-IgG-NMOSD at 45 (6\u201372; p=0.006). Isolated attacks involving the brainstem, cerebellum or both were less frequent in MOGAD (9\/39 (23%)) than MS (22\/30 (73%); p&lt;0.001) but not significantly different from AQP4-IgG-NMOSD (14\/30 (47%); p=0.07). Diffuse middle cerebellar peduncle MRI-lesions favoured MOGAD (17\/37 (46%)) over MS (3\/30 (10%); p=0.001) and AQP4-IgG-NMOSD (3\/30 (10%); p=0.001). Diffuse medulla, pons or midbrain MRI lesions occasionally occurred in MOGAD and AQP4-IgG-NMOSD but never in MS. Cerebrospinal fluid (CSF) oligoclonal bands were rare in MOGAD (5\/30 (17%)) and AQP4-IgG-NMOSD (2\/22 (9%); p=0.68) but common in MS (18\/22 (82%); p&lt;0.001). Disability at nadir or recovery did not differ between the groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Involvement of the brainstem, cerebellum or both is common in MOGAD but usually occurs as a component of a multifocal central nervous system attack rather than in isolation. We identified clinical, CSF and MRI attributes that can help discriminate MOGAD from AQP4-IgG-NMOSD and MS.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2020-325121","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T18:25:17Z","timestamp":1609179917000},"page":"384-390","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":116,"title":["Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS"],"prefix":"10.1136","volume":"92","author":[{"given":"Samantha A","family":"Banks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padraig P","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6140-5584","authenticated-orcid":false,"given":"Sean J","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4698-663X","authenticated-orcid":false,"given":"Elia","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-6491","authenticated-orcid":false,"given":"Amy","family":"Kunchok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Mendelt","family":"Tillema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G","family":"Weinshenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl N","family":"Krecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Sebastian","family":"Lopez-Chiriboga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy M","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia F","family":"Lucchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L","family":"Zalewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-2910","authenticated-orcid":false,"given":"Eoin P","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"key":"2024120323350764000_92.4.384.1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"2024120323350764000_92.4.384.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0719-z","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"2024120323350764000_92.4.384.3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes","volume":"77","author":"Waters","year":"2020","journal-title":"JAMA Neurol"},{"key":"2024120323350764000_92.4.384.4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"2024120323350764000_92.4.384.5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00415-018-8781-3","article-title":"Mri of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein","volume":"265","author":"Baumann","year":"2018","journal-title":"J Neurol"},{"key":"2024120323350764000_92.4.384.6","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1352458519845112","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","volume":"26","author":"de Mol","year":"2020","journal-title":"Mult Scler"},{"key":"2024120323350764000_92.4.384.7","first-page":"815","article-title":"Neuromyelitis optica spectrum disorder and other non\u2013multiple sclerosis central nervous system inflammatory diseases","volume":"25","author":"Flanagan","year":"2019","journal-title":"CONTINUUM: Lifelong Learning in Neurology"},{"key":"2024120323350764000_92.4.384.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1144-2","article-title":"Mog encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2024120323350764000_92.4.384.9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-Associated disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol"},{"key":"2024120323350764000_92.4.384.10","doi-asserted-by":"crossref","first-page":"10.1212\/WNL.0000000000007096","DOI":"10.1212\/WNL.0000000000007096","article-title":"A multicenter comparison of MOG-IgG cell-based assays","volume":"92","author":"Waters","year":"2019","journal-title":"Neurology"},{"key":"2024120323350764000_92.4.384.11","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000216139.44259.74"},{"key":"2024120323350764000_92.4.384.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"2024120323350764000_92.4.384.13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1515\/cclm-2017-0901","article-title":"Csf free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes","volume":"56","author":"Gurtner","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2024120323350764000_92.4.384.14","doi-asserted-by":"crossref","unstructured":"Budhram A , Kunchok A , Flanagan E . Adding fuel to the FLAMES: FLAIR-variable unilateral enhancement of the leptomeninges (fuel) in MOG-IgG-Associated disease 862. AAN Enterprises, 2020.","DOI":"10.1212\/WNL.94.15_supplement.862"},{"key":"2024120323350764000_92.4.384.15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0000000000008786","article-title":"Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)?","volume":"94","author":"Kunchok","year":"2020","journal-title":"Neurology"},{"key":"2024120323350764000_92.4.384.16","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1212\/WNL.0000000000006392","article-title":"Area postrema syndrome: frequency, criteria, and severity in AQP4-IgG-positive NMOSD","volume":"91","author":"Shosha","year":"2018","journal-title":"Neurology"},{"key":"2024120323350764000_92.4.384.17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/brain\/awaa102","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study","volume":"143","author":"Takai","year":"2020","journal-title":"Brain"},{"key":"2024120323350764000_92.4.384.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.08.002","article-title":"Mog antibody-related isolated rhombencephalitis revealed by paroxysmal dysarthria","volume":"405","author":"Kollmann","year":"2019","journal-title":"J Neurol Sci"},{"key":"2024120323350764000_92.4.384.19","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000543","article-title":"Cranial nerve involvement in patients with MOG antibody\u2013associated disease","volume":"6","author":"Cobo-Calvo","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024120323350764000_92.4.384.20","unstructured":"Fujimori J , Nakashima I . Linear pontine trigeminal root lesion in a patient with anti\u2010MOG antibody\u2010associated encephalitis. Clinical and Experimental Neuroimmunology."},{"key":"2024120323350764000_92.4.384.21","article-title":"Long-Term outcomes in patients with myelin oligodendrocyte glycoprotein immunoglobulin G\u2013Associated disorder","volume":"Online ahead of print","author":"Lopez-Chiriboga","year":"2020","journal-title":"JAMA Neurology"},{"key":"2024120323350764000_92.4.384.22","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"2024120323350764000_92.4.384.23","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311743"},{"key":"2024120323350764000_92.4.384.24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577002","article-title":"Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Beh\u00e7et's disease","volume":"334","author":"Fujimori","year":"2019","journal-title":"J Neuroimmunol"},{"key":"2024120323350764000_92.4.384.25","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314005"},{"key":"2024120323350764000_92.4.384.26","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513507822"},{"key":"2024120323350764000_92.4.384.27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000101"},{"key":"2024120323350764000_92.4.384.28","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.3.390"},{"key":"2024120323350764000_92.4.384.29","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1136(199609)18:1<39::AID-GLIA4>3.0.CO;2-Z"},{"key":"2024120323350764000_92.4.384.30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/jnnp.67.2.153","article-title":"Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis","volume":"67","author":"Nakashima","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024120323350764000_92.4.384.31","first-page":"1","article-title":"Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients","volume":"17","author":"Jarius","year":"2020","journal-title":"J Neuroinflammation"},{"key":"2024120323350764000_92.4.384.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01824-2","article-title":"Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients","volume":"17","author":"Jarius","year":"2020","journal-title":"J Neuroinflammation"},{"key":"2024120323350764000_92.4.384.33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamaneurol.2019.3656","article-title":"Coexistence of myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies in adult and pediatric patients","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA Neurol"},{"key":"2024120323350764000_92.4.384.34","first-page":"135245852090790","article-title":"Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies","volume":"1352458520907900","author":"Sechi","year":"2020","journal-title":"Mult Scler"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-325121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T07:37:13Z","timestamp":1733297833000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-325121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,28]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,3,12]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/jnnp-2020-325121"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-325121","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,28]]}}}